Diagnostic concordance among pathologists interpreting breast core biopsies on secondary review over a 1-year period at an Australian tertiary hospital.

Autor: Hohnen H; Royal Perth Hospital, Perth, WA, Australia., Dessauvagie B; Department of Anatomical Pathology, PathWest Laboratory Medicine, Fiona Stanley Hospital, Perth, WA, Australia.; School of Medicine, University of Western Australia, Perth, WA, Australia., Hardie M; Department of Anatomical Pathology, PathWest Laboratory Medicine, Fiona Stanley Hospital, Perth, WA, Australia.; Pathology and Laboratory Medicine, University of Western Australia, Perth, WA, Australia., McCallum D; Department of Anatomical Pathology, PathWest Laboratory Medicine, Fiona Stanley Hospital, Perth, WA, Australia., Oehmen R; School of Medicine, University of Notre Dame Fremantle, Perth, WA, Australia., Latham B; Department of Anatomical Pathology, PathWest Laboratory Medicine, Fiona Stanley Hospital, Perth, WA, Australia.; School of Medicine, University of Notre Dame Fremantle, Perth, WA, Australia.
Jazyk: angličtina
Zdroj: The breast journal [Breast J] 2021 Aug; Vol. 27 (8), pp. 664-670. Date of Electronic Publication: 2021 Jul 01.
DOI: 10.1111/tbj.14267
Abstrakt: This study provides data on the diagnostic concordance between initial and review diagnoses of all breast core biopsy cases at a single tertiary hospital in Western Australia over a 1-year period. A retrospective review of all breast core biopsy cases between January 1 and December 31, 2016, was carried out at PathWest, Fiona Stanley Hospital in Perth, Western Australia. Each biopsy is reported by a single pathologist and then reviewed within 1 week by a panel of intradepartmental subspecialist breast pathologists, who either agree with the original diagnosis, have a minor discordant diagnosis, or a major discordant diagnosis. Records for 2036 core biopsies were available between January 1 and December 31, 2016. Of these, 56.0% (n = 1141) were classified as benign, 34.3% (n = 699) as malignant, 7.2% (n = 147) as indeterminate, 2.3% (n = 46) as nondiagnostic, and 0.1% (n = 3) as suspicious for malignancy. In 99.1% (n = 2018) of cases, there was agreement between initial and review diagnoses. In total, 0.9% (n = 18) were disagreements: 0.49% (n = 10) were major discordant disagreements and 0.39% (n = 8) were minor discordant disagreements. All cases of major discordant disagreements would have resulted in significant changes to clinical management. This study demonstrates that an Australian institution is providing a high-quality pathology service with a low error rate between initial and review diagnoses of breast core biopsies. It reinforces the importance of secondary review of biopsies in a timely fashion for detecting potentially serious misdiagnoses that could lead to inappropriate management.
(© 2021 Wiley Periodicals LLC.)
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje